Takhzyro Caution For Usage

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Caution For Usage

Incompatibilities: Not applicable.
Special precautions for disposal and other handling: Lanadelumab is provided in single use vials and pre-filled syringes.
Before use, TAKHZYRO solution should be visually inspected for appearance. The solution should be clear or slightly yellow. Solutions that are discoloured or contain particles should not be used.
Avoid vigorous agitation.
Administration steps: After removing the pre-filled syringe from the refrigerator, wait 15-30 minutes before injecting to allow the solution to reach room temperature. Inject TAKHZYRO subcutaneously into the abdomen, thigh, or upper arm (see Dosage & Administration).
Each pre-filled syringe is for single use only. Discard the pre-filled syringe after injection is completed.
All needles and syringes should be disposed of in a sharps container.

Takhzyro Caution For Usage

lanadelumab

Manufacturer:

Takeda

Distributor:

Zuellig Pharma

Marketer:

Takeda